SE9702794D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9702794D0
SE9702794D0 SE9702794A SE9702794A SE9702794D0 SE 9702794 D0 SE9702794 D0 SE 9702794D0 SE 9702794 A SE9702794 A SE 9702794A SE 9702794 A SE9702794 A SE 9702794A SE 9702794 D0 SE9702794 D0 SE 9702794D0
Authority
SE
Sweden
Prior art keywords
new compounds
purinoceptor
transmembrane
processes
preparation
Prior art date
Application number
SE9702794A
Other languages
English (en)
Inventor
Nicholas Kindon
Premji Meghani
Stephen Thom
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Priority to SE9702794A priority Critical patent/SE9702794D0/sv
Publication of SE9702794D0 publication Critical patent/SE9702794D0/sv
Priority to US09/155,091 priority patent/US6200981B1/en
Priority to AU83704/98A priority patent/AU8370498A/en
Priority to PCT/SE1998/001391 priority patent/WO1999005123A1/en
Priority to DE69809242T priority patent/DE69809242D1/de
Priority to AT98934105T priority patent/ATE227276T1/de
Priority to JP2000504122A priority patent/JP2001510833A/ja
Priority to EP98934105A priority patent/EP1000038B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
SE9702794A 1997-07-24 1997-07-24 New compounds SE9702794D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE9702794A SE9702794D0 (sv) 1997-07-24 1997-07-24 New compounds
US09/155,091 US6200981B1 (en) 1997-07-24 1998-07-15 Pyrimidin derivatives
AU83704/98A AU8370498A (en) 1997-07-24 1998-07-15 Novel pyrimidin derivatives
PCT/SE1998/001391 WO1999005123A1 (en) 1997-07-24 1998-07-15 Novel pyrimidin derivatives
DE69809242T DE69809242D1 (de) 1997-07-24 1998-07-15 Neue pyrimidinderivate
AT98934105T ATE227276T1 (de) 1997-07-24 1998-07-15 Neue pyrimidinderivate
JP2000504122A JP2001510833A (ja) 1997-07-24 1998-07-15 新規なピリミジン誘導体
EP98934105A EP1000038B1 (en) 1997-07-24 1998-07-15 Novel pyrimidin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702794A SE9702794D0 (sv) 1997-07-24 1997-07-24 New compounds

Publications (1)

Publication Number Publication Date
SE9702794D0 true SE9702794D0 (sv) 1997-07-24

Family

ID=20407823

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702794A SE9702794D0 (sv) 1997-07-24 1997-07-24 New compounds

Country Status (8)

Country Link
US (1) US6200981B1 (sv)
EP (1) EP1000038B1 (sv)
JP (1) JP2001510833A (sv)
AT (1) ATE227276T1 (sv)
AU (1) AU8370498A (sv)
DE (1) DE69809242D1 (sv)
SE (1) SE9702794D0 (sv)
WO (1) WO1999005123A1 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999026944A1 (en) * 1997-11-21 1999-06-03 Astrazeneka Uk Limited New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists
US7179481B2 (en) * 2002-09-19 2007-02-20 Kimberly-Clark Worldwide, Inc. Vaginal health products
US7098189B2 (en) * 2002-12-16 2006-08-29 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
US7056889B2 (en) 2002-12-16 2006-06-06 Kimberly-Clark, Worldwide, Inc. Compounds that bind P2Y2 or P2Y1 receptors
US7485666B2 (en) * 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
ES2600460T3 (es) 2005-05-10 2017-02-09 Intermune, Inc. Derivados de piridona-2-ona como moduladores del sistema de proteína cinasa activada por estrés
DE602006009804D1 (de) 2005-06-02 2009-11-26 Hoffmann La Roche Piperidin-4-yl-amidderivate und ihre verwendung als antagonisten des sst-rezeptors vom subtyp 5
CA2726588C (en) 2008-06-03 2019-04-16 Karl Kossen Compounds and methods for treating inflammatory and fibrotic disorders
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
CN110452216B (zh) 2014-04-02 2022-08-26 英特穆恩公司 抗纤维化吡啶酮类

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997010220A1 (de) * 1995-09-12 1997-03-20 Bayer Aktiengesellschaft Uracil-derivate

Also Published As

Publication number Publication date
JP2001510833A (ja) 2001-08-07
ATE227276T1 (de) 2002-11-15
AU8370498A (en) 1999-02-16
EP1000038A1 (en) 2000-05-17
DE69809242D1 (de) 2002-12-12
US6200981B1 (en) 2001-03-13
WO1999005123A1 (en) 1999-02-04
EP1000038B1 (en) 2002-11-06

Similar Documents

Publication Publication Date Title
BR0015963A (pt) Compostos de uréia antagonistas receptor muscarìnico, composições farmacêuticas compreendendo tais compostos e método de preparação destes compostos
IT1304150B1 (it) Derivati di ammine cicliche che sono antagonisti di recettori ccr-3,composizioni farmaceutiche che li contengono, metodi per il loro
PT1009732E (pt) 1-amino-alquilciclo-hexanos antagonistas do receptor nmda
DK0856001T3 (da) Pyrimidinderivater som 5-HT2C-receptor-antagonister
NO996178D0 (no) 4-aminopyrrol(3,2-d)pyrimidiner som neuropeptid y- reseptorantagonister
SE9702651D0 (sv) Novel compounds
DE60225174D1 (de) Beta-3 adrenergische agonisten
NO993350L (no) Vitronectin-reseptor-antagonister
DK1068202T3 (da) 1-(-heteroarylpropyl- eller -prop-2-enyl)-4benzylpipderidiner som NMDA-receptor-antagonister
TR200002896T2 (tr) Kalsilitik Bileşimler
ID26223A (id) Antagonis reseptor vitronektin
SE9702794D0 (sv) New compounds
SE9702002D0 (sv) Novel compounds
DE50008020D1 (de) Substituierte pyrrolidin-2,3,4-trion-derivate wirksam als nmda-rezeptor-antagonisten
ID24468A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin
ID28811A (id) Antagonis reseptor vitronektin
AU1356299A (en) New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists
AU3611099A (en) Oxindole derivatives used as neurokinin receptor antagonists
DE69526738T2 (de) Endothelin-rezeptor-antagonisten
ID24309A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin
HUP0201725A3 (en) Indoloazepines as vasopressin receptor antagonists, their use, pharmaceutical compositions containing them and process for the preparation thereof
ATE310732T1 (de) 7-phenyl-1,4-diazepanderivate als neurokininrezeptorantagonisten
ID22978A (id) Antagonis reseptor endotelin
ID25461A (id) Turunan 2-ariletil-(piperidin-4-ilmetil)amina sebagai antagonis reseptor muskarinik